glp-1 long-term use safety Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Agonists: A Comprehensive Overview

Many studies have demonstrated the higher prevalence of thyroid dysfunction in both T1DM and T2DM

This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease

Retatrutide, a triple GIP/GLP-1/glucagon receptor agonist, normalized liver fat in 90 percent of patients after 48 weeks

You dont have to be taking more of it really frequently to maintain the effect

Available from: Open Resources for Nursing (Open RN)

In addition, there were five nonfunctional pNETs, two serotonin-expressing samples from one patient, and one gastrin-expressing tumor